• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从细胞毒性方法到细胞因子方法在血液净化迷宫中的转变:我们是否终于找到了阿里阿德涅的线?

Moving from a cytotoxic to a cytokinic approach in the blood purification labyrinth: have we finally found Ariadne's thread?

机构信息

Intensivist University Hospital, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

出版信息

Mol Med. 2012 Dec 20;18(1):1363-5. doi: 10.2119/molmed.2012.00300.

DOI:10.2119/molmed.2012.00300
PMID:23052299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3533646/
Abstract

For almost three decades, researchers have invested in strategies that involved removal of excess inflammatory mediators from the circulation (that is, the "cytotoxic" approach). Blood purification techniques using an extracorporeal device can indeed non-specifically remove a wide array of inflammatory mediators from the circulation. In animal models, this multimediator targeting or pleiotropic approach was shown to downregulate systemic inflammation and to restore immune homeostasis. In this issue, Namas et al. seriously challenge this cytotoxic hypothesis and propose to replace it by a cytokinic approach. In a rodent model of sepsis, these authors elegantly demonstrate that hemoadsorption using a large surface-area polymer could reduce and, more importantly, relocalize and reprogram sepsis-induced acute inflammation, while simultaneously lowering infectious burden and liver damage. Although challenging, this new theory can be considered complementary to the existing cytotoxic hypotheses by coupling reduced endothelial damage at the interstitial level (cytotoxic approach) with the concept of reprogramming leucocytes and mediators toward infected tissue, thus emptying the bloodstream of important promoters of remote organ damages (cytokinic approach).

摘要

近三十年来,研究人员一直在致力于从循环系统中清除多余的炎症介质的策略(即“细胞毒性”方法)。使用体外设备的血液净化技术确实可以非特异性地从循环系统中清除多种炎症介质。在动物模型中,这种针对多种介质或多效性的方法已被证明可以下调全身炎症并恢复免疫稳态。在本期杂志中,Namas 等人对这一细胞毒性假说提出了质疑,并提出用细胞因子方法来替代它。在脓毒症的啮齿动物模型中,这些作者巧妙地证明了使用大表面积聚合物的血液吸附可以减少,更重要的是,可以重新定位和重新编程脓毒症引起的急性炎症,同时降低感染负担和肝损伤。虽然具有挑战性,但通过将细胞间水平的内皮损伤降低(细胞毒性方法)与将白细胞和介质重新编程为感染组织的概念相结合,这种新理论可以被认为是对现有的细胞毒性假说的补充,从而清除了血液中重要的远程器官损伤的促进剂(细胞因子方法)。

相似文献

1
Moving from a cytotoxic to a cytokinic approach in the blood purification labyrinth: have we finally found Ariadne's thread?从细胞毒性方法到细胞因子方法在血液净化迷宫中的转变:我们是否终于找到了阿里阿德涅的线?
Mol Med. 2012 Dec 20;18(1):1363-5. doi: 10.2119/molmed.2012.00300.
2
Blood and plasma treatments: the rationale of high-volume hemofiltration.血液和血浆治疗:高容量血液滤过的基本原理。
Contrib Nephrol. 2007;156:387-95. doi: 10.1159/000102129.
3
Blood purification in sepsis: a new paradigm.脓毒症中的血液净化:一种新范式。
Contrib Nephrol. 2010;165:322-328. doi: 10.1159/000313773. Epub 2010 Apr 20.
4
Hemofiltration, adsorption, sieving and the challenge of sepsis therapy design.血液滤过、吸附、筛分与脓毒症治疗方案设计面临的挑战。
Crit Care. 2002 Oct;6(5):394-6. doi: 10.1186/cc1826. Epub 2002 Sep 4.
5
Clinical review: blood purification for sepsis.临床综述:脓毒症的血液净化治疗。
Crit Care. 2011;15(1):205. doi: 10.1186/cc9411. Epub 2011 Feb 16.
6
Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments.血小板活化因子在炎症和脓毒症中的相关性:体外治疗中清除的机制与动力学
Am J Kidney Dis. 1997 Nov;30(5 Suppl 4):S57-65. doi: 10.1016/s0272-6386(97)90543-6.
7
Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis.急性清除常见脓毒症介质并不能解释体外血液净化在实验性脓毒症中的作用。
Kidney Int. 2012 Feb;81(4):363-9. doi: 10.1038/ki.2011.320. Epub 2011 Sep 14.
8
Extracorporeal blood purification for sepsis.用于脓毒症的体外血液净化
Hong Kong Med J. 2016 Oct;22(5):478-85. doi: 10.12809/hkmj164876. Epub 2016 Aug 19.
9
Extracorporeal Blood Purification Therapies for Sepsis.脓毒症的体外血液净化疗法。
Blood Purif. 2019;47 Suppl 3:1-14. doi: 10.1159/000499520. Epub 2019 Apr 11.
10
A simple mathematical model of cytokine capture using a hemoadsorption device.一种使用血液吸附装置捕获细胞因子的简单数学模型。
Ann Biomed Eng. 2009 Jan;37(1):222-9. doi: 10.1007/s10439-008-9587-8. Epub 2008 Oct 24.

引用本文的文献

1
Extracorporeal blood purification strategies in sepsis and septic shock: An insight into recent advancements.脓毒症和脓毒性休克的体外血液净化策略:近期进展洞察
World J Crit Care Med. 2023 Mar 9;12(2):71-88. doi: 10.5492/wjccm.v12.i2.71.
2
Cytokine adsorption therapy in lymphoma-associated hemophagocytic lymphohistiocytosis and allogeneic stem cell transplantation.细胞因子吸附疗法在淋巴瘤相关噬血细胞性淋巴组织细胞增多症和异基因造血干细胞移植中的应用。
J Artif Organs. 2021 Sep;24(3):402-406. doi: 10.1007/s10047-020-01244-2. Epub 2021 Jan 18.
3
Effects of high volume haemodiafiltration on inflammatory response profile and microcirculation in patients with septic shock.高容量血液滤过对感染性休克患者炎症反应特征及微循环的影响。
Biomed Res Int. 2015;2015:125615. doi: 10.1155/2015/125615. Epub 2015 Apr 29.

本文引用的文献

1
Hemoadsorption reprograms inflammation in experimental gram-negative septic peritonitis: insights from in vivo and in silico studies.血液吸附通过体内和计算机模拟研究重编程实验性革兰氏阴性菌脓毒症腹膜炎中的炎症反应。
Mol Med. 2012 Dec 20;18(1):1366-74. doi: 10.2119/molmed.2012.00106.
2
Drotrecogin alfa (activated) in adults with septic shock.活化的人重组凝血因子 VII 治疗成人感染性休克。
N Engl J Med. 2012 May 31;366(22):2055-64. doi: 10.1056/NEJMoa1202290. Epub 2012 May 22.
3
High-volume hemofiltration in the intensive care unit: a blood purification therapy.高容量血液滤过在重症监护病房中的应用:一种血液净化治疗方法。
Anesthesiology. 2012 Jun;116(6):1377-87. doi: 10.1097/ALN.0b013e318256f0c0.
4
New insights regarding rationale, therapeutic target and dose of hemofiltration and hybrid therapies in septic acute kidney injury.关于脓毒症急性肾损伤行血液滤过和杂合治疗的基本原理、治疗靶点和剂量的新见解。
Blood Purif. 2012;33(1-3):44-51. doi: 10.1159/000333837. Epub 2011 Dec 15.
5
Septic AKI in ICU patients. diagnosis, pathophysiology, and treatment type, dosing, and timing: a comprehensive review of recent and future developments.ICU 患者的脓毒症急性肾损伤。诊断、病理生理学、治疗类型、剂量和时机:近期和未来发展的综合回顾。
Ann Intensive Care. 2011 Aug 9;1(1):32. doi: 10.1186/2110-5820-1-32.
6
In vitro evaluation of high mobility group box 1 protein removal with various membranes for continuous hemofiltration.使用各种用于连续性血液滤过的膜对高迁移率族蛋白B1进行体外清除评估。
Ther Apher Dial. 2011 Aug;15(4):385-93. doi: 10.1111/j.1744-9987.2011.00971.x.
7
Clinical review: blood purification for sepsis.临床综述:脓毒症的血液净化治疗。
Crit Care. 2011;15(1):205. doi: 10.1186/cc9411. Epub 2011 Feb 16.
8
Recent trials in critical care nephrology.
Contrib Nephrol. 2010;165:299-309. doi: 10.1159/000313770. Epub 2010 Apr 20.
9
Intensity of continuous renal-replacement therapy in critically ill patients.危重症患者持续肾脏替代治疗的强度
N Engl J Med. 2009 Oct 22;361(17):1627-38. doi: 10.1056/NEJMoa0902413.
10
Epidemiology of severe sepsis in the intensive care unit.重症监护病房中严重脓毒症的流行病学
Br J Hosp Med (Lond). 2008 Aug;69(8):442-3. doi: 10.12968/hmed.2008.69.8.30739.